-
Libtayo's FDA Approval: What to Expect from this Novel PD-1 Inhibitor
Libtayo's FDA Approval: What to Expect from this Novel PD-1 Inhibitor Dr. Andrew Merron, Executive Director, DRG Oncology A true milestone event in oncology occurred this September 2018 when the FDA...
-
Cardiovascular and Orthopedic Device Markets in China: The Rise of Domestic Competitors
This live session took place on September 20, 2018 Rapid growth in the Chinese cardiovascular and orthopedic market and large foreseeable opportunities have attracted significant investment from both...
-
Market Snapshot: Neurostimulation
DRG, in partnership with Bloomberg Intelligence, has delved into the competitive neurostimulation market, analyzing factors such as market share and hospital penetration by brand. Check out our...
-
BI and DRG Analyst Briefing: An Analysis of the Increasingly Competitive Neurostimulation Market
This live session took place on September 18, 2018 in partnership with Bloomberg Intelligence The world-wide neurostimulation market is catching the eye of many within the medtech, pharmaceutical and...
-
Market Snapshot: The US Market for Spinal Implants
Are your IBD’s innovative? Do you know the five keys to a successful ASC strategy? Is nonfusion a lucrative market? Check out our snapshot on the US Spinal Implants market to learn more. &...
-
Transforming the Treatment of Suicidal Ideation in Major Depressive Disorder
Suicidal ideation and imminent risk of suicide are two conditions that are prevalent among major depressive disorder (MDD) patients. Despite the high prevalence of these conditions, currently approved...
-
Advanced Patient Segmentation Strategies for Today’s Personalized Markets
Learn how to get a more complete picture of your patient populations.
-
Blood Cancer Awareness Month: Key Trends in the Hematology Oncology Market
Blood Cancer Awareness Month: Key Trends in the Hematology Oncology Market Dr. Andrew Merron, Executive Director, DRG Oncology For Blood Cancer Awareness Month, Dr. Andrew Merron discusses major...
-
Latest HPA findings reveal shifting dynamics in national and regional healthcare
As part of our effort to offer the very latest in Health Plan Analysis, DRG is pleased to offer this high-level view of our latest findings on national and regional trends. These insights offer an...
-
The Impact of Medical Devices on Healthcare Delivery – Challenges to and Benefits of Implementation
DRG conducted a literature review with the objective of identifying published examples of service impact and system design models for innovative non-pharmaceutical health technologies. This white...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
